The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects chlamydia, gonorrhea and trichomoniasis, according to a press release.

The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis, three of the most common STIs with symptoms that often go unnoticed.

Cartoonist Art Spiegelman, best known for his Pulitzer Prize-winning graphic novel Maus, about his parents’ survival of the Holocaust, has had an immense impact on the world of comics throughout ...

Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of chlamydia infection. The company plans to begin a phase I/II study soon ...

Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 clinical study evaluating the immunogenicity and ...

The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of ...

There is currently no FDA-approved vaccine for the prevention of chlamydia infection. Image credit: Shutterstock / Wirestock Creators. The US Food and Drug Administration (FDA) has granted fast track ...

(IN BRIEF) Sanofi’s mRNA vaccine candidate for chlamydia has been granted fast track designation by the US FDA, reflecting its promising potential to address a significant public health issue.